The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis

Clin Rheumatol. 2009 Jan;28(1):41-6. doi: 10.1007/s10067-008-0980-3. Epub 2008 Sep 16.

Abstract

The objective of this study was to investigate the frequency of sacroiliitis in familial Mediterranean fever (FMF) patients and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. The study group consisted of 256 FMF patients (male 128, female 128, mean age 27.2 +/- 6.3 years). After evaluation of the medical records, 70 patients (27.4%) were determined to have one or more of musculoskeletal manifestations. Sacroiliitis was determined in 18 (32.7%) FMF patients. The frequency of sacroiliitis among all FMF patients was found to be 7%. HLA-B27 was 47% and 6.3% in FMF patients with and without sacroiliitis, respectively. The frequency of M694V mutations in FMF patients with sacroiliitis was 93.7%. Sacroiliitis may be seen more frequently in FMF patients than expected. HLA-B27 positivity and/or M694V mutation may play a role in the development of sacroiliitis and the severity of seronegative spondyloarthropathy.

MeSH terms

  • Adolescent
  • Adult
  • Cytoskeletal Proteins / genetics*
  • Familial Mediterranean Fever / complications*
  • Familial Mediterranean Fever / diagnosis
  • Familial Mediterranean Fever / genetics
  • Female
  • HLA-B27 Antigen / genetics*
  • Health Status
  • Humans
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Point Mutation
  • Pyrin
  • Radiography
  • Retrospective Studies
  • Sacroiliac Joint / diagnostic imaging*
  • Sacroiliac Joint / physiopathology
  • Severity of Illness Index
  • Spondylitis, Ankylosing / diagnosis
  • Spondylitis, Ankylosing / etiology*
  • Spondylitis, Ankylosing / genetics
  • Young Adult

Substances

  • Cytoskeletal Proteins
  • HLA-B27 Antigen
  • MEFV protein, human
  • Pyrin